ST. LOUIS, Sept. 2, 2011 /PRNewswire/ -- Allied Healthcare Products, Inc., (NASDAQ: AHPI) reported a profitable fourth quarter and fiscal year despite sluggish sales to hospitals and government entities still suffering from recession-driven budget cuts.

Allied announced net income of about $204,000, or 3 cents per basic and diluted share, for the 2011 fiscal year compared to a loss of about $600,000, or a negative 7 cents per share, for the previous year.

For the quarter, Allied increased net income to about $115,000, or 1 cent per basic and diluted share, from about $86,000, or 1 cent per share, for the previous year.

Allied sales for the fiscal year ended June 30, 2011, increased by about $750,000, or nearly 2 percent, to about $46.8 million. Sales for the fourth quarter increased by almost $434,000, or 3.5 percent, to about $12.1 million compared to the previous year's fourth quarter.

Allied reduced selling, general and administrative (SG&A) expenses in the 2011 fiscal year by more than 10 percent, from about $11.9 million to $10.6 million.  Selling, general and administrative expenses in the prior year were affected by a non-cash charge of $609,000 for the grant of stock options.

"Domestic sales to hospitals and emergency markets increased modestly in this fiscal year," said Earl Refsland, Allied president and chief executive officer. "But both markets remain significantly below pre-recession levels." Refsland said that sales in Allied's international markets also remain well below pre-recession levels.

"Our cost structure is strong, so Allied is well positioned to take advantage of the markets' return to more normal demand levels," Refsland said.

Allied ended the 2011 fiscal year with more than $6 million in cash, Refsland said.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical products dealers.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements."  Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.

ALLIED HEALTHCARE PRODUCTS, INC.

CONSOLIDATED STATEMENT OF OPERATIONS

(UNAUDITED)



















Three months ended,



Twelve months ended,



June 30,



June 30,



2011



2010



2011



2010

















Net sales

$12,101,826



$11,668,246



$46,783,436



$46,034,248

Cost of sales

9,068,116



8,772,006



35,780,657



34,944,714

Gross profit

3,033,710



2,896,240



11,002,779



11,089,534

















Selling, general and administrative expenses

2,813,753



2,674,223



10,593,869



11,871,758

Income (loss) from operations

219,957



222,017



408,910



(782,224)

















Interest income

(9,041)



(5,764)



(32,733)



(10,168)

Interest expense

-



1,505



66



4,269

Other, net

10,219



13,599



78,150



117,189



1,178



9,340



45,483



111,290

















Income (loss) before provision for















(benefit from) income taxes

218,779



212,677



363,427



(893,514)

















Provision for (benefit from) income taxes

104,053



126,412



159,019



(293,941)

Net income (loss)

$114,726



$86,265



$204,408



($599,573)

















Net income (loss) per share - Basic

$0.01



$0.01



$0.03



($0.07)

















Net income (loss) per share - Diluted

$0.01



$0.01



$0.03



($0.07)

















Weighted average common shares outstanding - Basic

8,124,386



8,093,386



8,107,313



8,066,740

















Weighted average common shares outstanding - Diluted

8,136,743



8,112,373



8,124,957



8,066,740





ALLIED HEALTHCARE PRODUCTS, INC.

CONSOLIDATED BALANCE SHEET

(UNAUDITED)















June 30, 2011



June 30, 2010

ASSETS







Current assets:









Cash and cash equivalents

$   6,512,887



$   5,263,324



Accounts receivable, net of allowances









 of $300,000

5,366,860



5,418,253



Inventories, net

10,553,289



11,155,456



Income tax receivable

95,578



877,665



Other current assets

213,745



221,840



   Total current assets

22,742,359



22,936,538



Property, plant and equipment, net

8,660,507



9,661,395



Other assets, net

362,480



333,084



   Total assets

$ 31,765,346



$ 32,931,017











LIABILITIES AND STOCKHOLDERS' EQUITY







Current liabilities:









Accounts payable

$   1,644,910



$   1,950,446



Other accrued liabilities

1,645,552



2,241,259



Deferred income taxes

512,572



429,699



Deferred revenue

688,200



688,200



   Total current liabilities

4,491,234



5,309,604











Deferred revenue

114,700



802,900











Commitments and contingencies

















Stockholders' equity:









Preferred stock; $0.01 par value; 1,500,000 shares









 authorized; no shares issued and outstanding

-



-



Series A preferred stock; $0.01 par value; 200,000 shares









 authorized; no shares issued and outstanding

-



-



Common stock; $0.01 par value; 30,000,000 shares









 authorized; 10,427,878 and 10,396,878  shares issued









 at June 30, 2011 and June 30, 2010, respectively;









 8,124,386 and 8,093,386 shares outstanding at









 June 30, 2011 and June 30, 2010, respectively

104,279



103,969



Additional paid-in capital

48,499,103



48,362,922



Accumulated deficit

(712,542)



(916,950)



Less treasury stock, at cost; 2,303,492 shares at









  June 30, 2011 and June 30, 2010, respectively

(20,731,428)



(20,731,428)



   Total stockholders' equity

27,159,412



26,818,513



   Total liabilities and stockholders' equity

$ 31,765,346



$ 32,931,017





SOURCE Allied Healthcare Products, Inc.

Copyright 2011 PR Newswire

Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Allied Healthcare Products Charts.
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Allied Healthcare Products Charts.